Correction to: Real-World Safety and Effectiveness of an 8-Week Regimen of Glecaprevir/Pibrentasvir in Patients with Hepatitis C and Cirrhosis.Mei Lu,Loralee B Rupp,Christina Melkonian,Sheri Trudeau,Yihe G Daida,Mark A Schmidt,Stuart C GordonAdvances in therapy(2024)引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要